ID3 and neoplasm: In the first, we used the p53−/− TNBC tumor model where IHC analysis revealed that ~ 5% of neoplastic cells expressed Id1, consistent with the observation in the clinical samples, while Id3 marked a majority of the tumor cells in this model (Figure 1A).